event tracking

Parkinson’s Disease

170 results.

September 15, 2025 Cure Parkinson’s and Van Andel Institute announce Professor Matthew Farrer as winner of the 2025 Tom Isaacs Award

GRAND RAPIDS, Mich. (Sept. 15, 2025) — The annual Tom Isaacs Award, jointly presented by Cure Parkinson’s and Van Andel Institute (VAI), honors…

April 30, 2025 Explainer: What is the endolysosomal pathway?

Our cells create a lot of waste and, just like us, they need a way to get rid of it.

That’s the job of the…

April 28, 2025 Explainer: What is alpha-synuclein?

Alpha-synuclein (α-synuclein) is a protein most known for its involvement in Parkinson’s disease.

We have α-synuclein throughout our tissues, with the highest…

April 14, 2025 Van Andel Institute to recognize Dr. J. Timothy Greenamyre with 2025 Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research

GRAND RAPIDS, Mich. (April 14, 2025) — Van Andel Institute has named renowned physician-scientist
J. Timothy Greenamyre, M.D., Ph.D., as…

April 14, 2025 University of Minnesota, Van Andel Institute receive two-year, $5.8M grant to study Parkinson’s disease and cellular senescence

GRAND RAPIDS, Mich. (April 14, 2025) — Aging is the most important risk factor for neurodegenerative diseases, including Parkinson’s disease. However, the connection between aging…

March 21, 2025 The building blocks of brain cells

The human brain is home to billions of cells, each playing an essential role in our ability to think, feel and move. But what needs…

February 21, 2025 2025 Winter Neurodegeneration Summit: What’s on the horizon in neurodegeneration research?

Collaboration and connection are critically important in science.

Now in its second year, the Winter Neurodegeneration Summit provides an outstanding opportunity for early career…

February 7, 2025 After the recent exenatide results, what’s next in Parkinson’s disease research and clinical trials?

Earlier this week, The Lancet published results of a phase 3 clinical trial that explored whether the Type 2 diabetes medication exenatide could…